Improved method of dilating pupils for ophthalmic exams under anesthesia (faster and easier).

Child Health (pediatrics) Mydriasis Pupil Retina Retinoblastoma

Journal

Asia-Pacific journal of oncology nursing
ISSN: 2347-5625
Titre abrégé: Asia Pac J Oncol Nurs
Pays: United States
ID NLM: 101673157

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 28 02 2024
accepted: 17 06 2024
medline: 6 8 2024
pubmed: 6 8 2024
entrez: 6 8 2024
Statut: epublish

Résumé

The pupils of children with retinoblastoma are routinely dilated pre-procedure with Tropicamide and Phenylephrine. Despite that, the pupil constricts once general anesthesia begins. The aim of this study is to see if adding Ketorolac to the regular dilating drops given pre-procedure shortens the length of anesthesia. Retrospective comparison of time under anesthesia for two groups of retinoblastoma children receiving anesthesia for examination under anesthesia: one group (January 1, 2019 to October 1, 2022) had been dilated with Tropicamide 1% and Phenylephrine 2.5% while the second group (October 2, 2022 to July 1, 2023) was dilated with a combination drop using those drugs with topical Ketorolac 0.5% and Proparacaine 0.5%. Average anesthesia time for patients who received the older two-drug combination was 25 minutes vs. 16 minutes (36% reduction in exposure time) for those who received the newer four-drug combination (9 minutes less anesthesia) ( The use of a combined dilating drop that incorporated Tropicamide 1%, Phenylephrine 2.5%, Proparacaine 0.5% and Ketorolac 0.5% significantly shortened the time for exams under anesthesia for children with retinoblastoma because the pupil remained dilated after anesthesia induction with Sevoflurane. Using this combined drop, children will receive 5-10 hours less anesthesia during their treatment for retinoblastoma and staff will have more than 150 hours of fewer exposure to anesthetic gasses. In addition, far fewer drops are necessary pre-anesthesia, minimizing trauma to the children and families.

Identifiants

pubmed: 39104729
doi: 10.1016/j.apjon.2024.100543
pii: S2347-5625(24)00165-3
pmc: PMC11298878
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100543

Informations de copyright

© 2024 The Authors.

Auteurs

David H Abramson (DH)

Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Weill Cornell Medical College, New York, NY, USA.

Todd Liu (T)

Department of Anesthesiology & Critical Care, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Edith Guarini (E)

Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jacquelyn Gaccione (J)

Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Christina Bracken (C)

Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Andrea Bobin (A)

Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Angela Foerch (A)

Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Melissa A Robbins (MA)

Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ricardo Dodds Rojas (RD)

Digital Informatics & Technology Solutions, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jasmine H Francis (JH)

Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Weill Cornell Medical College, New York, NY, USA.

Classifications MeSH